Allakos Inc. (ALLK) Financials

ALLK Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 283.5 million 62.5 million
2023-06-30 319.2 million 64.2 million
2023-03-31 350.4 million 70.0 million
2022-12-31 386.4 million 76.0 million

ALLK Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -29.6 million 10.5 million
2023-06-30 -32.8 million 9.8 million
2023-03-31 -30.4 million 10.7 million
2022-12-31 -47.1 million 9.3 million

ALLK Net Income

No data available :(

ALLK Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 193.9 million - 41.8 million
2023-06-30 221.1 million - 39.7 million
2023-03-31 252.6 million - 43.4 million
2022-12-31 279.8 million - 49.1 million

ALLK Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 87.1 million
2023-06-30 86.6 million
2023-03-31 85.8 million
2022-12-31 85.3 million

ALLK Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 107000 36.7 million 11.5 million -
2023-06-30 252000 27.3 million 10.5 million -
2023-03-31 267000 33.1 million 12.0 million -
2022-12-31 291000 35.4 million 10.8 million -

ALLK Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1.5 million
2023-06-30 - 1.8 million
2023-03-31 - 2.0 million
2022-12-31 - 2.0 million

ALLK

Price: $1.10

52 week price:
1.00
5.64

Earnings Per Share: -2.14 USD

P/E Ratio: -0.80

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 140771

Market Capitalization: 105.4 million

Links: